News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
835,079 Results
Type
Article (85743)
Company Profile (696)
Press Release (748640)
Section
Business (232262)
Career Advice (4114)
Deals (39658)
Drug Delivery (122)
Drug Development (90736)
Employer Resources (194)
FDA (17993)
Job Trends (17277)
News (395642)
Policy (39632)
Tag
Academia (2973)
Alliances (56617)
Alzheimer's disease (1386)
Approvals (17932)
Artificial intelligence (188)
Bankruptcy (396)
Best Places to Work (12586)
Biotechnology (476)
Breast cancer (211)
Cancer (1566)
Cardiovascular disease (134)
Career advice (3519)
Cell therapy (340)
Clinical research (72171)
Collaboration (569)
Compensation (287)
COVID-19 (2810)
C-suite (140)
Data (1478)
Diabetes (199)
Diagnostics (6725)
Earnings (94838)
Employer resources (167)
Events (127503)
Executive appointments (485)
FDA (18773)
Funding (507)
Gene therapy (240)
GLP-1 (729)
Government (5050)
Healthcare (20775)
Infectious disease (2914)
Inflammatory bowel disease (127)
Interviews (808)
IPO (17662)
Job creations (5180)
Job search strategy (2856)
Layoffs (493)
Legal (10050)
Lung cancer (239)
Manufacturing (229)
Medical device (14465)
Medtech (14470)
Mergers & acquisitions (22202)
Metabolic disorders (550)
Neuroscience (1774)
NextGen: Class of 2025 (7650)
Non-profit (5070)
Northern California (1856)
Obesity (312)
Opinion (252)
Patents (135)
People (64501)
Pharmaceutical (143)
Phase I (22256)
Phase II (31347)
Phase III (23611)
Pipeline (615)
Postmarket research (3550)
Preclinical (10010)
Radiopharmaceuticals (260)
Rare diseases (300)
Real estate (7376)
Regulatory (26192)
Research institute (2643)
Resumes & cover letters (649)
Southern California (1590)
Startups (4279)
United States (17206)
Vaccines (666)
Weight loss (241)
Date
Today (199)
Last 7 days (944)
Last 30 days (2231)
Last 365 days (37092)
2025 (1366)
2024 (37382)
2023 (42568)
2022 (53928)
2021 (58724)
2020 (57670)
2019 (51341)
2018 (39125)
2017 (37191)
2016 (38330)
2015 (44433)
2014 (39673)
2013 (36268)
2012 (38416)
2011 (38383)
2010 (39616)
Location
Africa (1265)
Arizona (236)
Asia (49564)
Australia (8738)
California (4295)
Canada (1529)
China (353)
Colorado (192)
Connecticut (221)
Europe (113549)
Florida (589)
Georgia (147)
Illinois (483)
Indiana (257)
Maryland (716)
Massachusetts (3435)
Michigan (199)
Minnesota (334)
New Jersey (1211)
New York (1192)
North Carolina (903)
Northern California (1856)
Ohio (158)
Pennsylvania (998)
South America (1649)
Southern California (1590)
Texas (621)
Utah (123)
Washington State (459)
835,079 Results for "eos imaging formerly known as biospace med".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Biotech Bay
Henry Meds Revolutionizes Weight Loss Treatment with Oral Tirzepatide Dissolvable Tablets
Telehealth company Henry Meds, known for its commitment to patient-centric care, announced the launch of Compounded Oral Dissolving Tirzepatide Tablets.
May 28, 2024
·
2 min read
Business
Kane Biotech Signs Worldwide License Agreement with Montreal-Based I-MED Pharma Inc.First Commercial Agreement for DispersinB®
Kane Biotech Inc. announces that it has entered into a worldwide license agreement with I-MED Pharma Inc. (“I-MED Pharma” or “I-MED”) for the DispersinB ® technology.
June 25, 2024
·
3 min read
Press Releases
TTG Imaging Solutions Rebrands as Catalyst MedTech, Strengthening Focus on Innovation in Nuclear Medicine and Molecular Imaging
January 8, 2025
·
3 min read
BioCapital
Radon Medical Imaging Announces 5-Year Medical Imaging Asset Management Agreement with Vandalia Health
Radon Medical Imaging, a leading medical imaging equipment maintenance and repair services company, announced it was selected as the Medical Imaging Asset Management firm for several Vandalia Health facilities.
May 16, 2024
·
2 min read
Drug Development
Elevation Oncology Announces Planned Combination Strategy for EO-3021 in Patients with Gastric or Gastroesophageal Junction Cancer
Elevation Oncology, Inc. announced plans to expand its ongoing Phase 1 clinical trial to include two combination cohorts evaluating EO-3021 for the treatment of advanced gastric or gastroesophageal junction cancer.
June 27, 2024
·
8 min read
Job Trends
BioSpace
Announces 2025 Best Places to Work in Biopharma
BioSpace
has named 50 biopharma companies to its 2025 Best Places to Work list, including Moderna and Sutro Biopharma, whose executives share what makes their organizations special.
November 12, 2024
·
6 min read
·
Angela Gabriel
Press Releases
Empyrean Therapeutics Acquires TLR-2 Antagonist Molecule From Eos Therapies to Advance and Commercialize Breakthrough Cancer Treatment
November 26, 2024
·
3 min read
Press Releases
Enterome to Present New Clinical Data and Biomarker Findings for EO2463 at the 2024 American Society of Hematology (ASH) Annual Meeting
November 6, 2024
·
4 min read
NextGen
BioSpace
’s NextGen Class of 2025 Leans Into Biopharma’s Hottest Trends
From ADCs and radiopharmaceuticals to cell and gene therapies, eager young startups are betting on advances in biopharma’s most competitive therapeutic spaces—and attracting dollars from Big Pharma.
January 7, 2025
·
4 min read
·
Heather McKenzie
Enterome Highlights High Complete Response Rate in Clinical Study of EO2463 for Indolent Non-Hodgkin Lymphoma at ASCO 2024
Enterome announces updated immune-monitoring and clinical data from the ongoing EONHL1-20/SIDNEY trial evaluating EO2463 in monotherapy and in combination with lenalidomide and/or rituximab in indolent non-Hodgkin lymphoma.
May 24, 2024
·
7 min read
1 of 83,508
Next
